Holger Lawall Selected Research

sucrose octasulfate

10/2020	Impact of wound duration on diabetic foot ulcer healing: evaluation of a new sucrose octasulfate wound dressing.
12/2019	Cost-effectiveness of TLC-sucrose octasulfate versus control dressings in the treatment of diabetic foot ulcers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Holger Lawall Research Topics

Disease

12	Peripheral Arterial Disease 11/2022 - 08/2004
6	Diabetic Foot 10/2020 - 09/2008
5	Ulcer 10/2020 - 09/2008
4	Wounds and Injuries (Trauma) 10/2020 - 10/2009
3	Pain (Aches) 01/2020 - 04/2010
3	Intermittent Claudication 07/2017 - 07/2011
3	Chronic Limb-Threatening Ischemia 02/2011 - 09/2008
2	Hypertension (High Blood Pressure) 01/2022 - 07/2011
2	Venous Thromboembolism 01/2022 - 04/2008
2	Stroke (Strokes) 11/2020 - 07/2013
2	Infections 12/2019 - 01/2017
2	Carotid Stenosis (Carotid Artery Stenosis) 07/2013 - 04/2008
1	Diabetes Mellitus 11/2022
1	Obesity 01/2022
1	Pathologic Constriction (Stenosis) 11/2020
1	Inflammation (Inflammations) 10/2019
1	Overweight 01/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2018
1	Ischemia 10/2016
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2014
1	Atherosclerosis 02/2011
1	Thromboangiitis Obliterans (Buerger's Disease) 02/2011
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2011
1	Necrosis 10/2009
1	Hemorrhage 09/2008
1	Abdominal Aortic Aneurysm 04/2008

Drug/Important Bio-Agent (IBA)

2	sucrose octasulfateIBA 10/2020 - 12/2019
2	Oxygen (Dioxygen)IBA 02/2011 - 04/2010
1	RivaroxabanIBA 01/2022
1	PowdersIBA 01/2021
1	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2021
1	Interleukin-6 (Interleukin 6)IBA 10/2019
1	canakinumab FDA Link 10/2019
1	C-Reactive ProteinIBA 10/2019
1	Nicotine FDA Link 01/2019
1	oxidized low density lipoproteinIBA 01/2018
1	Alprostadil (Muse)FDA LinkGeneric 01/2017
1	Pentoxifylline (Trental)FDA LinkGeneric 01/2017
1	Nebivolol FDA Link 07/2011
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 07/2011
1	Troleandomycin (TAO)FDA Link 02/2011
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 09/2008
1	AnticoagulantsIBA 04/2008

Therapy/Procedure

10	Therapeutics 11/2022 - 08/2004
9	Surgical Amputation (Amputations) 01/2022 - 09/2008
3	Conservative Treatment 11/2020 - 10/2009
2	Stents 11/2022 - 04/2008
2	Carotid Endarterectomy 11/2020 - 07/2013
2	Contraindications 01/2020 - 07/2011
2	Negative-Pressure Wound Therapy 01/2020 - 08/2014
1	Aftercare (After-Treatment) 10/2019
1	Endovascular Procedures 10/2016
1	Ambulatory Care (Outpatient Care) 08/2014
1	Critical Care (Surgical Intensive Care) 07/2014
1	Analgesia 10/2009
1	Length of Stay 10/2009